WordNet

be a contributing factor; "make things factor into a companys profitability"
any of the numbers (or symbols) that form a product when multiplied together
an independent variable in statistics
anything that contributes causally to a result; "a number of factors determined the outcome"
consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
a concept whose truth can be proved; "scientific hypotheses are not facts"
a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
present at birth but not necessarily hereditary; acquired during fetal development (同)inborn, innate

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 小児における紫斑の評価 evaluation of purpura in children
2. 児童虐待疑いの鑑別診断 differential diagnosis of suspected child abuse
3. 止血障害を有する患者における内視鏡処置 endoscopic procedures in patients with disorders of hemostasis
4. 血漿分画製剤および組換えDNA産生凝固因子 plasma derivatives and recombinant dna produced coagulation factors
5. 小児における鼻出血の疫学および病因 epidemiology and etiology of epistaxis in children

The Canadian "National Program for hemophilia mutation testing" database: A ten-year review.

Natalia R, Jayne L, Shawn T, Paula J, David L.SourceMedicine, University of Calgary, Calgary, Alberta, Canada.
American journal of hematology.Am J Hematol.2013 Dec;88(12):1030-4. doi: 10.1002/ajh.23557. Epub 2013 Sep 9.
A reference genotyping laboratory was established in 2000 at Queen's University, Kingston, to provide genetic testing for Hemophilia A (HA) and B (HB) and create a Canadian mutation database. Canadian hemophilia treatment centers and genetics clinics provided DNA and clinical information from Novemb
PMID 23913812

Lison S, Spannagl M.SourceKlinik für Anaesthesiologie, Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie, Klinikum der Universität München, Marchioninistr. 15, 81377, München, Deutschland, susanne.lison@med.uni-muenchen.de.
Der Anaesthesist.Anaesthesist.2013 Nov 24. [Epub ahead of print]
Hemophilia A and hemophilia B are X chromosome-linked congenital bleeding disorders caused by a deficiency or absence of activity of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B), which are graded in different degrees of severity (mild, moderate, severe). Depending on the severi
PMID 24270937

Platelet gene therapy corrects the hemophilic phenotype in immunocompromized hemophilia A mice transplanted with genetically manipulated human cord blood stem cells.

Shi Q, Kuether EL, Chen Y, Schroeder JA, Fahs SA, Montgomery RR.SourceDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States;
Blood.Blood.2013 Nov 22. [Epub ahead of print]
Our previous studies have demonstrated that platelet-FVIII (2bF8) gene therapy can improve hemostasis in hemophilia A mice even in the presence of inhibitory antibodies, but none of our studies has targeted human cells, only mouse cells. Here we evaluated the feasibility for lentivirus (LV)-mediated
PMID 24269957

石黒精
日本臨床免疫学会会誌 = Japanese journal of clinical immunology 34(6), 476-484, 2011-12-31
… 血友病は血液凝固第VIII因子（FVIII）を先天的に欠失するために起こる，X連鎖遺伝性の凝固障害症である．欠乏する凝固因子は予防的にまたは出血時に補充されている．輸注された凝固因子製剤中のFVIIIを阻害する同種抗体が出現することは血友病治療の重大な合併症である．この抗体を臨床的にはインヒビターと呼んでいる．インヒビターを保有する血友病患者では，通常の凝固因子製剤の止血効果は著しく低下ま …
NAID 10030465231